Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Novel Immunological Biomarkers for Allogeneic HSCT Outcome
  • Language: en
  • Pages: 259
Molecular and Immunological Advances in Hematological Malignancies: Volume II
  • Language: en
  • Pages: 114
Real-World Data and Real-World Evidence in Hematologic Malignancies
  • Language: en
  • Pages: 196
The EBMT Handbook
  • Language: en
  • Pages: 840

The EBMT Handbook

None

Engineered immune cells in cancer immunotherapy (EICCI)
  • Language: en
  • Pages: 659
Multiple Myeloma
  • Language: en
  • Pages: 128

Multiple Myeloma

This book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow–microenvironment interactions.

Adoptive Immunotherapy
  • Language: en
  • Pages: 499

Adoptive Immunotherapy

An authoritative collection of optimal techniques for producing and characterizing the immunologically active cells and effector molecules now gaining wide use in the clinical treatment of patients. Taking advantage of the latest technologies, the authors present readily reproducible experimental protocols for the study of dendritic cells, T cells, monoclonal antibodies, and bone marrow transplantation. The emphasis is on preclinicical and clinical applications and on the progress of selected approaches in clinical trials. Additional chapters cover the molecular definition of target antigens, mathematical modeling approaches to immunotherapy, and the utilization of regulatory T cells. The protocols make it possible to study the adoptive transfer of tailored antigen-specific immune cells and to improve the clinical application of adoptive immunotherapy.

AACR 2022 Proceedings: Part A Online-Only and April 10
  • Language: en
  • Pages: 2287

AACR 2022 Proceedings: Part A Online-Only and April 10

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Cancer Immune Therapy
  • Language: en
  • Pages: 448

Cancer Immune Therapy

Cure or life with cancer? What can be achieved by cancer immune therapy? The past decade has seen substantial advancements in tumor immunology. Much of the new knowledge has been translated into new strategies for cancer treatment and into clinical trials. Some of these trials herald future breakthroughs, others have been disappointing and have prompted intensive search for alternatives.Major contributors to the field summarize the knowledge on the molecular and cellular mechanisms of tumorigenesis, critically review the instruments of the immune system that might be exploited for therapy, and discuss the clinical experiences with the different immune therapy concepts. Researchers in the fields of immunology, tumor biology and medicine will highly appreciate this up-to-date volume for evaluating future research activities.